Tao Zhang

机构：Shanghai Public Health Clinical Center · ORCID：0000-0002-9769-8921

发表论文 45 篇 · 总被引 513 次 · h-index 12

代表论文

• Discovery and Crystallographic Studies of Nonpeptidic Piperazine Derivatives as Covalent SARS-CoV-2 Main Protease Inhibitors (2022 · Journal of Medicinal Chemistry · 被引 36)
• Characterisations of Lactobacillus reuteri SK24.003 glucansucrase: Implications for α-gluco-poly- and oligosaccharides biosynthesis (2016 · Food Chemistry · 被引 28)
• Effectiveness of 13-valent pneumococcal conjugate vaccine against community acquired pneumonia among children in China, an observational cohort study (2021 · Vaccine · 被引 22)
• Development of Novel Dihydrofuro[3,4- d ]pyrimidine Derivatives as HIV-1 NNRTIs to Overcome the Highly Resistant Mutant Strains F227L/V106A and K103N/Y181C (2022 · Journal of Medicinal Chemistry · 被引 20)
• Rational design to improve the catalytic efficiency and stability of arginine deiminase (2024 · International Journal of Biological Macromolecules · 被引 14)
• Incidence of community-acquired pneumonia among children under 5 years in Suzhou, China: a hospital-based cohort study (2024 · BMJ Open · 被引 12)